Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome. by Signorini, Cinzia et al.
Research Article
Redox Imbalance and Morphological Changes in
Skin Fibroblasts in Typical Rett Syndrome
Cinzia Signorini,1 Silvia Leoncini,1,2 Claudio De Felice,3 Alessandra Pecorelli,1,2
Ilaria Meloni,4 Francesca Ariani,4 Francesca Mari,4 Sonia Amabile,4
Eugenio Paccagnini,5 Mariangela Gentile,5 Giuseppe Belmonte,6 Gloria Zollo,1,2
Giuseppe Valacchi,7 Thierry Durand,8 Jean-Marie Galano,8 Lucia Ciccoli,1
Alessandra Renieri,4,9 and Joussef Hayek2
1 Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy
2 Child Neuropsychiatry Unit, University Hospital Azienda Ospedaliera Universitaria Senese (AOUS), 53100 Siena, Italy
3 Neonatal Intensive Care Unit, University Hospital AOUS, Policlinico “S. M. alle Scotte,” 53100 Siena, Italy
4Medical Genetics, University of Siena, 53100 Siena, Italy
5 Department of Life Sciences, University of Siena, 53100 Siena, Italy
6Department of Medicine Surgery and Neuroscience, University of Siena, 53100 Siena, Italy
7 Department of Life Science and Biotechnologies, University of Ferrara, 44121 Ferrara, Italy
8 Institut des Biomole´cules Max Mousseron (IBMM), UMR 5247-CNRS-UM I-UM II-ENSCM, BP 14491 34093,
Montpellier Cedex 5, France
9Genetica Medica, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy
Correspondence should be addressed to Cinzia Signorini; cinzia.signorini@unisi.it and Claudio De Felice; geniente@gmail.com
Received 10 March 2014; Revised 9 May 2014; Accepted 12 May 2014; Published 29 May 2014
Academic Editor: Ozcan Erel
Copyright © 2014 Cinzia Signorini et al.This is an open access article distributed under theCreativeCommonsAttribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Evidence of oxidative stress has been reported in the blood of patients with Rett syndrome (RTT), a neurodevelopmental disorder
mainly caused by mutations in the gene encoding the Methyl-CpG-binding protein 2. Little is known regarding the redox status
in RTT cellular systems and its relationship with the morphological phenotype. In RTT patients (n = 16) we investigated four
different oxidative stress markers, F
2
-Isoprostanes (F
2
-IsoPs), F
4
-Neuroprostanes (F
4
-NeuroPs), nonprotein bound iron (NPBI),
and (4-HNE PAs), and glutathione in one of the most accessible cells, that is, skin fibroblasts, and searched for possible changes in
cellular/intracellular structure and qualitative modifications of synthesized collagen. Significantly increased F
4
-NeuroPs (12-folds),
F
2
-IsoPs (7.5-folds) NPBI (2.3-folds), 4-HNE PAs (1.48-folds), and GSSG (1.44-folds) were detected, with significantly decreased
GSH (−43.6%) andGSH/GSSG ratio (−3.05 folds). Amarked dilation of the rough endoplasmic reticulum cisternae, associatedwith
several cytoplasmic multilamellar bodies, was detectable in RTT fibroblasts. Colocalization of collagen I and collagen III, as well as
the percentage of type I collagen as derived by semiquantitative immunofluorescence staining analyses, appears to be significantly
reduced in RTT cells. Our findings indicate the presence of a redox imbalance and previously unrecognized morphological skin
fibroblast abnormalities in RTT patients.
1. Introduction
Rett syndrome (RTT) predominantly affects females with an
incidence of 1 in 10,000–15,000 female births [1, 2]. In its
typical form, affected patients exhibit various neuropsychi-
atric features after 6–18months [3] of apparently normal neu-
rodevelopment. Although phenotypical heterogeneity which
determines the clinical severity of the disease is a typical
feature of RTT [4], key clinical aspects include autistic
traits, epileptic seizures, breathing abnormalities, gait ataxia,
stereotypies, and loss of finalistic hands use [3]. Mutations
in the gene encoding the Methyl-CpG-binding protein 2
(MECP2) account for approximately 90%of caseswith typical
RTT and are almost exclusively de novo [4]. Nine most
Hindawi Publishing Corporation
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 195935, 10 pages
http://dx.doi.org/10.1155/2014/195935
2 Oxidative Medicine and Cellular Longevity
frequent mutations comprise more than 3/4 of all the
reported pathogenic ones [5]; in addition,MECP2 genemuta-
tions are usually categorized as missense or truncating,
including nonsense, frameshift, and large deletions, accord-
ing to the type of sequence change.
Oxidative stress (OS) indicates a combination of events
resulting in a damage to biological molecules due to an
imbalance between cellular antioxidant defences and free
radicals production. OS appears to be involved in a large
number of human diseases, including cancer [6–8] neurode-
generative diseases [9, 10] and inflammatory bowel disease
[11]. Furthermore, cumulating evidence suggests the presence
of a redox imbalance in autism spectrum disorders (ASDs),
a condition with a high social impact due to the explosive
increase in its prevalence over the last four decades [12–18].
Our group and other laboratories have reported enhancedOS
markers levels in plasma and erythrocytes from patients with
RTT, thus suggesting the presence of a systemic OS in the
disease. However, to date, it is unclear not only why, but also
when, and where this OS derangement may occur [19–26].
In particular to date, little is known regarding the oxidant-
antioxidant status in RTT cellular systems and its possible
relationship with the morphological phenotype. Here, we
investigated the levels of different OS markers (F
2
-IsoPs, F
4
-
NeuroPs, NPBI, and 4-HNE PAs) and glutathione in primary
skin fibroblasts from patients with typical RTT, as well as
possible changes in the cellular/intracellular structure and/or
qualitative changes in the synthesized collagen.
2. Materials and Methods
2.1. Subjects. A total of 16 female patients with typical RTT
(mean age: 13.06 ± 6.5), as well as 8 healthy female controls
of comparable age (mean age: 13.2 ± 6.8), participated in the
study. Skin biopsies from the control group were obtained
from a skin biobank by selecting subjects without diagnosed
skin or collagen diseases (responsibility: Joussef Hayek).
All patients were consecutively admitted to the Child
Neuropsychiatry Unit of the University Hospital of Siena
(Head: Joussef Hayek). For all patients theMECP2mutation
was demonstrated (mutation categories: missense mutation
𝑛 = 8; early truncating mutation 𝑛 = 6; late truncating
mutation 𝑛 = 2), and a clinical severity score was calculated
using the previously reported scaling system [27] (mean
severity score: 15.9 ± 6.47; range: 5.0–28.0). All the examined
subjects were on a typical Mediterranean diet.
A 3mm skin punch biopsy was performed after obtained
written informed consent of either the parents or the legal
tutors of the patients (responsibility: Joussef Hayek). Biopsies
from control subject were performed in the Dermatology
Unit of the University Hospital of Siena. The study was con-
ducted with the approval of the Institutional Review Board
of the University Hospital Azienda Ospedaliera Universitaria
Senese.
2.2. Fibroblasts Isolation and Culture. Following informed
consent signature, skin biopsies (about 3-4mm3) were per-
formed using the Punch Biopsy procedure. Fibroblasts were
isolated and cultured with standard protocols [28]. Cells were
grown in DMEM (Biochrom), supplemented with 10% fetal
bovine serum, 100U/mL penicillin, 100 𝜇g/mL streptomycin,
and 2mM L-glutamine. Cells were incubated at 37∘C with
5% CO
2
until 80–90% confluence and routinely passed by
trypsin-EDTA (Irvine Scientific).
Cells for analysis were seeded onto 100mm tissue culture
plates (for NPBI and IsoP evaluations) and 12-well plates
(for 4-HNE PAs and GSH/GSSG ratio) containing the indi-
cated medium formulations. Fibroblasts at low passage were
employed for the analysis.
At confluence, the cells were scraped, transferred in a
tube, and washed twice with ice-cold PBS pH 7.4. Cells
were then centrifuged at 600 g for 10min and the pellet
resuspended in a final volume of 2mL PBS.
2.3. Nonprotein Bound Iron (NPBI). Nonprotein bound iron
was determined as desferoxamine- (DFO-) chelatable free
iron (DFO-iron complex, ferrioxamine). DFO 25𝜇M was
added to 1mL of cell suspension to obtain a final concen-
tration of 25𝜇M DFO and the cells were ruptured by the
addition of 1mL water, freeze-thawing, and sonication. The
samples were then ultrafiltered in centrifuge filter devices
(VIVASPIN 4, Sartorius Stedim Biotech GmbH, Goettingen,
Germany) with a 30 kDa molecular weight cutoff and the
ultrafiltrate was stored at −20∘C until analysis. The DFO
excess was removed by silica (Silicagel 25–40𝜇m; Merck,
Darmstadt, Germany) column chromatography (Varian Inc.,
CA, USA).TheDFO-iron complex was determined by HPLC
and the detection wavelength was 229 nm [29].
2.4. Total (Sum of Free Plus Esterified) F
2
-Isoprostanes and F
4
-
Neuroprostanes Determinations. Butylated hydroxytoluene
was added to 900𝜇L of cell suspension as an antioxidant
to obtain a final concentration of 90 𝜇M and the samples
were frozen at −70∘C until analysis. All isoprostane and
neuroprostane determinations were carried out by gas chro-
matography/negative ion chemical ionization tandem mass
spectrometry (GC/NICI-MS/MS) analysis after solid phase
extraction and derivatization steps. F
2
-Isoprostanes and F
4
-
neuroprostanes levels were normalized for the cell protein
content.
2.5. Solid Phase Extraction and Derivatization Procedures. At
the time of the determination, the samples were sonicated by
ultrasound treatment for 30 seconds and then purified as pre-
viously reported [29]. Briefly, aqueous KOH (1mM, 450𝜇L)
was added to the cellular suspension. After incubation at
45∘C for 45min, the pH was adjusted to 3 by adding HCl
(1mM, 450 𝜇L). Each sample was spiked with tetradeuterated
prostaglandin F
2𝛼
(PGF
2𝛼
-d
4
) (500 pg in 50𝜇L of ethanol),
as an internal standard, and ethyl acetate (10mL) was added
to extract total lipids by vortex-mixing and centrifugation at
1,000 g for 5min at room temperature. The total lipid extract
was applied onto an NH
2
cartridge and the isoprostanes
in the final eluates were derivatized. The carboxylic group
was derivatized as the pentafluorobenzil ester whereas the
hydroxyl groups were converted to trimethylsilyl ethers [30].
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2.6. F
2
-Isoprostane GC/NICI-MS/MS. Measured ions were
the product ions at m/z 299 and m/z 303 derived from
the [M−181]− precursor ions (m/z 569 and m/z 573) pro-
duced from 15-F
2t-IsoPs and the tetradeuterated derivative of
prostaglandin F
2𝛼
(PGF
2𝛼
-d
4
), respectively [29, 30].
2.7. F
4
-NeuroPs GC/NICI-MS/MS. Measured ions were the
product ions at m/z 323 and m/z 303 derived from the
[M−181]− precursor ions (m/z 593 and m/z 573) produced
from oxidized DHA and the tetradeuterated derivative of
PGF
2𝛼
, respectively [29, 31].
2.8. Intracellular Redox Status. Usually, cellular glutathione
(GSH) exists mainly in the reduced form whereas the oxi-
dized disulfide form (GSSG) is present in small amounts.
The GSH/GSSG ratio is often taken as an indicator of
cellular redox status. Intracellular GSH and GSSG levels were
determined by an enzymatic recycling procedure according
to Tietze [32] and Baker et al. [33]. The SH group of
the molecule reacts with 5,5󸀠-dithiobis(2-nitrobenzoic acid)
(DTNB), producing a yellow-coloured 5-thio-2-nitrobenzoic
acid (TNB), and the disulfide is reduced by NADPH in
the presence of GSH reductase. GSSG was determined after
derivatization step of GSH by reaction with 2-vinylpyridine.
The rate of TNB formation was monitored at 420 nm. GSH
and GSSG levels were normalized for protein content.
At confluence, aftermedium removal, cultured fibroblasts
were washed twice with PBS pH 7.4 and treated with 5% 5-
sulfosalicylic acid (w/v) solution for 30min at 4∘C.The acidic
extracts were stored at −70∘C until the assay. The protein
extracts were obtained by cellular lysis with NaOH 0.1M.
2.9. 4-HNE Protein Adducts. 4-HNE PAs are markers of
protein oxidation due to aldehyde binding from lipid perox-
idation sources [34], determined by Western blot technique.
Cell proteins (30 𝜇g protein, as determined by using Bio-Rad
protein assay; BioRad, Hercules, CA, USA) were resolved on
4–20% SDS-PAGE gels (Lonza Group Ltd., Switzerland) and
transferred onto a hybond ECL nitrocellulosemembrane (GE
Healthcare EuropeGmbH,Milan, Italy). After blocking in 3%
nonfat milk (BioRad, Hercules, CA, USA), the membranes
were incubated overnight at 4∘C with goat polyclonal anti 4-
HNE adduct antibody (cod. AB5605; Millipore Corporation,
Billerica, MA, USA). Following washes in TBS Tween and
incubation with specific secondary antibody (mouse anti-
goat horseradish peroxidase-conjugated, Santa Cruz Biotech-
nology Inc., CA, USA) for 1 h at room temperature, the
membranes were incubated with ECL reagents (BioRad,
Hercules, CA, USA) for 1min. The bands were visualized by
autoradiography. Quantification of the relevant bands was
performed by digitally scanning the Amersham Hyperfilm
ECL (GE Healthcare Europe GmbH, Milan, Italy) and mea-
suring immunoblotting image densitieswith ImageJ software.
2.10. Transmission Electron Microscopy (TEM). Cultured
fibroblasts were fixed in 2.5% glutaraldehyde in 0.1M cacody-
late buffer pH 7.2 (CB) for 3 hours at 4∘C. After a rinse in
CB, the material was postfixed in 1% osmium tetroxide in CB
for 2 hours at 4∘C, dehydrated in a graded series of alcohol,
embedded in Araldite resins, and polymerized in oven for
48 hours at 60∘C. Sixty nm thin sections, obtained with a
Reichert ultramicrotome, were routinely stained with uranyl
acetate and lead citrate and observed with a TEM Fei Tecnai
G2 spirit at 100Kv.
2.11. Immunofluorescence Double Staining. The localization
of two main type of collagen synthetized by skin fibroblasts
was evaluated by an immunofluorescence assay. Primary
human fibroblasts, grown on glass coverslips at a density
of 2 × 104 cells/cm2, were fixed in 4% paraformaldehyde
for 10min at 4∘C. After fixation and permeabilization for
10min at room temperature with 0.1% Triton X-100, cells
were blocked for 30min at room temperature with PBS
containing 5% BSA. Fibroblasts were then incubated with
primary antibodies for collagen I and collagen III (Thermo
Fisher Scientific Inc., Rockford, IL, USA) in PBS with 1%
BSA at 4∘C overnight. After washing, cells were incubated
with secondary antibodies Alexa Fluor 568 and Alexa Fluor
488 (Life Technologies Corporation, Monza, Italy) for 1 h at
room temperature. Nuclei were stained with 1 𝜇g/mL DAPI
(Sigma-Aldrich S.r.l., Milan, Italy) for 1min. Coverslips were
mounted onto glass slides using antifade mounting medium
1,4-diazabicyclooctane in glycerine (DABCO). Observations
and photographs were made with a Leitz Aristoplan light
microscope (Leica, Milan, Italy) equipped with fluorescence
apparatus. Incubation in primary antibodies was omitted in
negative controls.
The relative intensity of fluorescence was measured in
regions of interest (ROI) by using the Software LEICA
AF6000 (Leica Microsystems-Germany).
2.12. Statistical Analysis. Results were expressed as medians
with interquartile ranges or means ± standard deviation.
Differences between groups were evaluated by the non-
parametric Mann-Whitney rank sum test, Wilcoxon rank
test, or Kruskal-Wallis test analysis of variance (ANOVA),
as appropriate. The MedCalc ver. 12.1.4 statistical software
package (MedCalc. Software, Mariakerke, Belgium) was used
for data analysis. Two-sided 𝑃 values <0.05 were considered
as significant.
3. Results
3.1. Cell Oxidant and Antioxidant Status. Biochemical signs
of lipid and protein oxidative damage, together with the
antioxidant cellular defense, were evaluated in skin fibroblasts
from RTT and healthy control subjects. Increased lipid
oxidative damage was evidenced as indicated by increased
levels of total (i.e., sum of free and esterified form) F
2
-IsoPs
(7.5-folds) and F
4
-NeuroPs (12-folds), both deriving from
membrane polyunsaturated fatty acids, that is, arachidonic
(AA) and docosahexaenoic (DHA) acid, respectively (Figures
1(a) and 1(b)). Biochemical signs of protein oxidative damage
consequent to a lipid peroxidation event were indicated
by increased (1.48-folds) 4-HNE PAs levels for which a
significant increase was also detected (Figure 1(c)). Oxidative
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Figure 1: Increased levels of total (i.e., sum of free and esterified form) F
2
-IsoPs, total F
4
-NeuroPs, 4-HNE PAs, and NPBI in RTT skin fibrob-
last as compared to the control cells. ∗
𝑃
< 0.0001, ∗∗
𝑃
= 0.0013. Data are expressed as means ± standard deviation. Legend: F
2
-IsoPs,
F
2
-isoprostanes; F
4
-NeuroPs, F
4
-neuroprostanes; 4-HNE PAs, 4-hydroxy-2-nonenal protein adducts; NPBI, nonprotein bound iron.
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Figure 2: Significant reduction in cellular GSH and significant increase of GSSG in RTT skin fibroblast as compared to control cells. ∗
𝑃
<
0.0001, ∗∗
𝑃
= 0.0033. Data are expressed as means ± standard deviation. Legend: GSH reduced glutathione; GSSG, oxidized glutathione.
damage was concomitant to an imbalance in the principal
antioxidant cytoplasmic agent in so far as a significant
reduction (−43.6%) in cellular GSH, a significant increase
(1.44-folds) of GSSG (Figures 2(a) and 2(b)), and a significant
reduction (−3.05 folds) of GSH/GSSG ratio were reported.
Lipid peroxidation events in RTT skin fibroblasts were found
to be related to the levels of NPBI, a prooxidant agent.
NPBI was significantly increased (2.3-folds) (Figure 1(d)),
with significant positive correlations observed between NPBI
and total cellular F
4
-NeuroPs (Rho = 0.84, 𝑃 = 0.001) and
NPBI versus total cellular F
2
-IsoPs (Rho = 0.69, 𝑃 = 0.019).
No significant relationships between each of the investigated
molecules (i.e., F
2
-IsoPs, F
4
-NeuroPs, 4-HNE Pas, GSH and
GSSG) and theMECP2mutation categories were observed (𝑃
value range: 0.461–0.981).
3.2. Cell Morphology Study. To evaluate the effect, if present,
of the oxidant/antioxidant imbalance evidenced in RTT
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Figure 3: Transmission electron microscopy of control (a) and RTT (b) fibroblasts cultures. Skin fibroblasts, either from control subjects
or RTT patients, show a flattened morphology with extensive tapering cytoplasmic processes. An euchromatic and oval-shaped nucleus
was present in central position of the cells, with clumps of heterochromatin next to the nuclear envelope. The cytoplasm contains many
vesicles with variable electron density, a prominent Golgi complex, and mitochondria. Rough endoplasmic reticulum (RER) cisternae in
RTT fibroblasts appear more dilated than in control. Some large multilamellar bodies (MLB) are frequently detectable in the cytoplasm of
the RTT fibroblast cells. (G) Golgi complex, (M) mitochondrion, and (V) vesicle. Bar = 1𝜇m.
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Figure 4: Double immunofluorescence staining shows the localization of type I collagen (central column, red color) and type III collagen
(left column, green color). Images are merged in the right panel and the yellow color indicates overlap of the staining. The colocalization of
types I and III collagen is reduced in RTT skin fibroblasts. Legend: Col I, type I collagen; Col III, type III collagen.
fibroblasts, the physiological cellular condition was evaluated
by observation of two key typical features: the morphology
and the collagen distribution.
At transmission electron microscope significant ultra-
structural differences between control and RTT fibroblasts
were observed. In particular, a marked dilation of the rough
endoplasmic reticulum cisternae was detectable in the skin
RTT fibroblasts, along with evidence of cytoplasmic multil-
amellar bodies (Figures 3(a) and 3(b)). Immunofluorescence
double staining showed a reduced degree of colocalization
of type III and type I collagen in RTT skin fibroblasts when
compared to control cells. Staining for type I collagen was
found to be more evident in RTT cells, where perinuclear
granules were also detectable (Figure 4). Likewise, in these
same cells, fluorescence relative intensity for type I collagen
was significantly reduced (𝑃 = 0.00997) (Figure 5).
4. Discussion
Our findings demonstrate, for the first time, the presence
of an extensive redox imbalance in primary skin fibroblasts
cultures obtained from patients with RTT by adding new
evidence to the concept of an OS imbalance as key pheno-
typical features of MeCP2 deficiency in RTT. Earlier clues
for an abnormal OS balance in RTT patients harbouring
MECP2 gene mutations are to date limited to plasma and
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Figure 5: Relative intensity of fluorescence for types I and type
III collagen in RTT and control skin fibroblasts. Software LEICA
AF6000 (Leica Microsystems-Germany). Data are expressed as
median ± semiinterquartile range ∗
𝑃
= 0.0062; N.S.: no significant
difference (𝑃 = 0.4361). Legend: Col I, type I collagen; Col III, type
III collagen.
erythrocytes samples [26, 35]. Although enhanced plasmatic
OS markers levels suggest a systemic OS status, to date no
indications are present in order to infer what tissues/cellular
systems other than blood could be potentially damaged by
the OS imbalance in RTT. A preliminary suggestion that an
oxidative process should occur at the cellular level was con-
tained in our recent study where oxidative posttranslational
modifications on SRB1 receptor in primary fibroblast cultures
were observed [36]. Fibroblasts have been used in the RTT
scientific research to evaluate gene mutation and epigenetic
process [37], differentiation to induced pluripotent stem (iPS)
[38], cellular response subsequent to MECP2 mutation [39],
reduction of stathmin-like 2 [40], and the effects of NB54
and other rationally designed aminoglycoside derivatives as
potential therapeutic agents for nonsenseMECP2 mutations
in RTT [41]. Fibroblasts have been extensively employed
to investigate OS in different pathophysiological processes
such as genetic neurodegenerative diseases [42], Parkinson’s
disease [43], aging [44], and response to etiological agents
[45, 46]. Moreover, lipid peroxidation events are known to
be relevant to the fibroblast function, as relationship between
mechanotransduction and lipid metabolites has been previ-
ously investigated in keloids [47].
The biochemical markers so far employed for measuring
OS are not to be considered as equal in terms of the con-
veyed information. In particular, F
2
-IsoPs, the gold standard
molecules for the OS in vivo evaluation [35, 48], are the
end-products of arachidonic acid (AA) oxidation, a polyun-
saturated fatty acid abundant in both brain grey and white
matter. On the other hand, F
4
-NeuroPs are the oxidative
end-products of docosahexanoic acid (DHA), abundant in
neuronal membranes [49]. NPBI is a prooxidant factor, asso-
ciated with hypoxia, hemoglobin oxidation, and subsequent
heme iron release [50].
Our data demonstrate that both AA and DHA undergo
significant oxidation in RTT fibroblasts. Although DHA is
known to be particularly abundant in neuronal membranes,
this fatty acid represents a normal constituent of all cell
membranes. In particular, human fibroblasts are able to
synthetize DHA [51] and incorporate it in their membrane
phospholipids [52]. Furthermore, variations of the DHA
content in the membrane of fibroblasts have been implicated
in neuropsychiatric disorders, with lowered levels evidenced
in patients with schizophrenia and bipolar disorder [53]. Our
results indicate an increased oxidation ofDHA inRTTfibrob-
lasts, thus underlying an increased susceptibility of these cells
to oxidative damage. This process, in turn, could contribute
to changes in the fatty acid composition of membranes with
consequent cellular damage.
4HNE, which is formed from arachidonic acid or other
unsaturated fatty acids following free radical attack, can bind,
byMichael addition, to proteins, particularly, to cysteine, his-
tidine, or lysine residues.Thanks to its ability to form adducts
to the proteins, 4HNE is not only considered as a reliable
marker of OS, but also has a biological impact by changing
protein function [34]. Our findings of increased 4HNE-PAs
can be considered as a long-term consequence of enhanced
lipid peroxidation, further contributing to cellular damage.
Glutathione, the main cellular antioxidant defence, pre-
venting the damage to key cellular components induced by
reactive oxygen species, exists in both reduced (GSH) and
oxidized (GSSG) states. In its reduced state, the thiol group of
cysteine is able to donate a reducing equivalent (H+ + e−) to
other unstable molecules, such as ROS, whereas in donating
an electron, glutathione itself becomes reactive but is ready to
react with another reactive glutathione to form GSSG.
Our reported results of decreased GSH levels and
GSH/GSSG ratio indicate a reduced antioxidant defence in
RTT cells and suggest that oxidative events are likely to be
chronic, thus determining a consumption of glutathione in
its reduced form. An alternative explanation could be that the
MECP2mutation-harboring cellsmayhave coexisting defects
in the synthesis and/or recycling of glutathione, thus leading
to an uncontrolled free radicals action. Of course, further
study is needed in order to clarify this point.
Overall, our data indicate that a significant oxidation of
DHA, the precursor acid for F
4
-NeuroPs, and AA, precursor
of F
2
-IsoPs, likely triggered by NPBI, occurs in skin fibrob-
lasts of patients withMECP2mutation and clinical RTT and
confirm the biological relevance of such keymediators of lipid
peroxidation.
Skin dermis is known to be consisting of 80% collagen
type I, with its remaining fraction being made mostly of
collagen type III [54]. In this context, the fibroblast shows a
pivotal role for collagen production, [55].
Besides being a major component of the extracellular
matrix in a variety of internal organs and skin in adults, type
III collagen is critical for fibrillogenesis in the development
of apparatus such as skin and cardiovascular system [56, 57].
Overall in such tissues, type III collagen is colocalized, within
the same fibril, with themost abundantmember of the family,
type I collagen, and regulates the diameter of type I collagen
fibrils, which have to meet the physiological requirements of
different tissues at different developmental stages [54, 58–62].
The reported ultrastructural changes are to be considered
as a new finding to be added to the mitochondrial changes
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previously reported in RTT skin fibroblasts [63]. Since no
abnormalities in wound repair and/or healing have been
reported in RTT patients, these ultrastructural features are
to be considered as subclinical characteristics of the disease.
Marked dilation of the rough endoplasmic reticulum cister-
nae and cytoplasmic multilamellar bodies were observed for
the first time in this study. Dilated rough endoplasmic retic-
ulum cisternae can be considered as a nonspecific adaptive
response due to either increased secretory activity or as the
result of the cellular response to noxae of different nature [64,
65]. On the other hand, the presence of multilamellar bodies
could be interpreted as an expression of cellular damage.
In particular, those structures suggest the occurrence of
autophagy phenomena of unclear pathogenesis [66].
A condition of oxidative stress has been previously
reported in aging skin [67]. Skin aging is known to be mainly
due to fragmentation/loss of type I collagen fibrils, conferring
strength, and resiliency in association withmetalloproteinase
activation, involved in type I collagen degradation [68].
Although, no evidence of wound healing alterations or derma
laxity has not been reported in RTT, an accelerated ageing
process is known to occur in the affected patients. Our results
suggest the occurrence of a possible reduction in type I
collagen, a feature of aging skin, while they show a clear redox
imbalance in RTT skin fibroblasts.Therefore, it is conceivable
that a premature skin aging may occur in RTT patients, a
hypothesis which is in line with prior evidence of premature
senescence phenomena in the disease [69–72].
Given that OS is known to be a major determinant of
aging [73, 74], it is conceivable that aging phenomena in
RTT, including skin fibroblasts morphological changes, may
be caused through OS mechanisms.
5. Conclusion
Our study demonstrates for the first time the occurrence
of lipid peroxidation in RTT fibroblasts, together with a
reduced antioxidant cellular defense with a major impact on
cell morphology. We speculate about a possible functional
involvement of these changes in the skin fibroblasts of RTT
patients which must be taken into account when evaluating
this cellular model of the disease. Our findings suggest that
OS is a generalized phenomenon in RTT, thus affecting
cellular systems and tissues apparently unrelated to the
central nervous system.
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